Piermont Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-4,460
| Closed | -$298K | – | 121 |
|
|
2018
Q2 | $298K | Sell |
4,460
-880
| -16% | -$58.8K | 0.09% | 213 |
|
|
2018
Q1 | $311K | Sell |
5,340
-830
| -13% | -$48.3K | 0.1% | 221 |
|
|
2017
Q4 | $398K | Sell |
6,170
-360
| -6% | -$23.2K | 0.13% | 195 |
|
|
2017
Q3 | $343K | Sell |
6,530
-6,510
| -50% | -$342K | 0.11% | 215 |
|
|
2017
Q2 | $610K | Sell |
13,040
-2,250
| -15% | -$105K | 0.17% | 212 |
|
|
2017
Q1 | $757K | Buy |
15,290
+8,050
| +111% | +$399K | 0.18% | 192 |
|
|
2016
Q4 | $439K | Sell |
7,240
-140
| -2% | -$8.49K | 0.1% | 238 |
|
|
2016
Q3 | $490K | Buy |
+7,380
| New | +$490K | 0.12% | 237 |
|